Zobrazeno 1 - 10
of 36
pro vyhledávání: '"Aliyah Pabani"'
Autor:
Sadia Ahmed, Jessica Simon, Patricia Biondo, Vanessa Slobogian, Lisa Shirt, Seema King, Alessandra Paolucci, Aliyah Pabani, Desiree Hao, Emi Bossio, Ralph Cross, Tim Monds, Jane Nieuwenhuis, Aynharan Sinnarajah
Publikováno v:
Research Involvement and Engagement, Vol 10, Iss 1, Pp 1-10 (2024)
Abstract Purpose Timely access to supportive and palliative care (PC) remains a challenge. A proposed solution is to trigger an automatic referral process to PC by pre-determined clinical criteria. This study sought to co-design with patients and pro
Externí odkaz:
https://doaj.org/article/a510ffdb76c14277b534326add2e15e5
Autor:
Chloe Ahryung Lim, Sunita Ghosh, Hali Morrison, Daniel Meyers, Igor Stukalin, Marc Kerba, Desiree Hao, Aliyah Pabani
Publikováno v:
Current Oncology, Vol 30, Iss 12, Pp 10396-10407 (2023)
The PACIFIC trial led to a new standard of care for patients with locally advanced lung cancer, but real-world practice has demonstrated that immune checkpoint inhibitor (ICI) pneumonitis can lead to significant clinical complications. This study aim
Externí odkaz:
https://doaj.org/article/effea2a6f0be42d7b9b6ef97fd2e41c6
Autor:
Jarushka Naidoo, Igor Puzanov, Paolo A Ascierto, Marc S Ernstoff, Douglas B Johnson, Fei Ye, Mitchell S von Itzstein, David E Gerber, Benjamin Switzer, Aliyah Pabani, Hannah Burnette, Run Fan
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 12, Iss 5 (2024)
Background Artificial intelligence (AI) chatbots have become a major source of general and medical information, though their accuracy and completeness are still being assessed. Their utility to answer questions surrounding immune-related adverse even
Externí odkaz:
https://doaj.org/article/10149fdee8db4c7899ea1632bcd5d0b9
Autor:
Dylan E. O’Sullivan, Tamer N. Jarada, Amman Yusuf, Leo (Xun Yang) Hu, Priyanka Gogna, Darren R. Brenner, Erica Abbie, Jennifer B. Rose, Kiefer Eaton, Julia Elia-Pacitti, Emmanuel M. Ewara, Aliyah Pabani, Winson Y. Cheung, Devon J. Boyne
Publikováno v:
Current Oncology, Vol 29, Iss 10, Pp 7198-7208 (2022)
Real-world evidence surrounding EGFR positive NSCLC patients in Canada is limited. Administrative databases in Alberta, Canada were used to evaluate EGFR testing and mutation prevalence in de novo metastatic NSCLC, as well as the characteristics, tre
Externí odkaz:
https://doaj.org/article/edf5dbbb360b4f88b187a35e6a95da2f
Autor:
Daniel E. Meyers, MD, MSc, Meghann Pasternak, MD, MSc, Samantha Dolter, MD, Heidi A.I. Grosjean, MD, Chloe A. Lim, MD, Igor Stukalin, MD, Siddhartha Goutam, MD, Vishal Navani, M.B.B.S., MRCP, Daniel Y.C. Heng, MD, MPH, Winson Y. Cheung, MD, PhD, Don G. Morris, MD, PhD, Aliyah Pabani, MD
Publikováno v:
JTO Clinical and Research Reports, Vol 4, Iss 4, Pp 100482- (2023)
Introduction: Landmark trials testing immune checkpoint inhibitors (ICIs) in advanced NSCLC are difficult to extrapolate to real-world practice given the exclusion of patients with poor (i.e., ≥2) Eastern Cooperative Oncology Group performance stat
Externí odkaz:
https://doaj.org/article/60af4c1049ba410eb0ed27eb16724e8a
Autor:
Amanda J.W. Gibson, BSc (Hons), Aliyah Pabani, MD, Michelle L. Dean, BSc, Guillermo Martos, MD, Winson Y. Cheung, MD, MPH, FRCPC, Vishal Navani, M.B.B.S., MRCP, FRACP
Publikováno v:
JTO Clinical and Research Reports, Vol 4, Iss 3, Pp 100460- (2023)
Introduction: BRAF mutations (present in 2%–3% of NSCLC) are a known oncogenic driver and emerging therapeutic target. There is a scarcity of real-world data describing the clinical characteristics, treatment patterns, and effectiveness of targeted
Externí odkaz:
https://doaj.org/article/e78d94bf195a4c678af18447c01445fa
Autor:
Amanda J. W. Gibson, Adrian Box, Winson Y. Cheung, Michelle L. Dean, Anifat A. Elegbede, Desiree Hao, Aliyah Pabani, Randeep Sangha, Dafydd Gwyn Bebb
Publikováno v:
Current Oncology, Vol 29, Iss 3, Pp 1967-1982 (2022)
The use, safety and effectiveness of crizotinib as part of the management of ROS1-rearranged NSCLC patients in a real-world Canadian clinical cohort was the focus of this retrospective review. Twenty-one ROS1-rearranged patients with advanced/metasta
Externí odkaz:
https://doaj.org/article/33b2527c355d4727adee66470c7c3b95
Autor:
Lillian Sung, Danielle Rodin, Rouhi Fazelzad, Vanessa F Bratti, Brooke E Wilson, Aliyah Pabani, Shalini J Zurn, Sonali Johnson
Publikováno v:
BMJ Open, Vol 13, Iss 2 (2023)
Introduction Antimicrobial resistance (AMR) is a growing global public health concern and is becoming a significant challenge in the management of patients with cancer. Due to the immunosuppressive nature of cancer treatment, infection is a common co
Externí odkaz:
https://doaj.org/article/c2c01273610849fcb177b711dc458d5d
Autor:
Heidi A. I. Grosjean, Samantha Dolter, Daniel E. Meyers, Philip Q. Ding, Igor Stukalin, Siddhartha Goutam, Shiying Kong, Quincy Chu, Daniel Y. C. Heng, D. Gwyn Bebb, Don G. Morris, Winson Y. Cheung, Aliyah Pabani
Publikováno v:
Current Oncology, Vol 28, Iss 5, Pp 4213-4222 (2021)
The emergence of immunotherapy revolutionized the treatment of non-small-cell-lung cancer (NSCLC), with multiple landmark clinical trials establishing the efficacy of these agents. However, many patients who receive immunotherapy in clinical practice
Externí odkaz:
https://doaj.org/article/ef1a3db40d2d4a92a300be45448be0e8
Autor:
Michael S. Sander, Igor Stukalin, Isabelle A. Vallerand, Siddhartha Goutam, Benjamin W. Ewanchuk, Daniel E. Meyers, Aliyah Pabani, Don G. Morris, Daniel Y. C. Heng, Tina Cheng
Publikováno v:
Cancer Medicine, Vol 10, Iss 8, Pp 2618-2626 (2021)
Abstract Background Metastatic uveal melanoma (MUM) is associated with poor survival and inferior response to immune checkpoint inhibitor (ICI) therapy when compared with metastatic cutaneous melanoma. Currently, prognostic biomarkers are lacking to
Externí odkaz:
https://doaj.org/article/912792318bd545cba1e0cd7fc036db6d